Advertisement

Topics

Acasti nets $9.3mm via FOPO

14:40 EST 3 Jan 2018 | Elsevier Business Intelligence

Acasti Pharma Inc. (lead candidate is CaPre for severe hypertriglyceridemia) netted $9.3mm through the follow-on public offer...

Original Article: Acasti nets $9.3mm via FOPO

NEXT ARTICLE

More From BioPortfolio on "Acasti nets $9.3mm via FOPO"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Hyperlipidemia - high cholesterol (hypercholesterolaemia)
Hyperlipidemia involves abnormally elevated levels of any or all lipids and/or lipoproteins in the blood. Lipids are transported in a protein capsule, the size of that capsule, or lipoprotein, determines its density. The lipoprotein density and type...

Clincial Trials
In a clinical trial or interventional study, participants receive specific interventions according to the research plan or protocol created by the investigators. These interventions may be medical products, such as drugs or devices; procedures; or change...